OneMedNet Announces Strategic Alliance with Cytel to Enhance Real-World Data Solutions

OneMedNet and Cytel Join Forces

OneMedNet Corporation, a prominent player in the real-world data (RWD) solutions sector, has announced a strategic alliance with Cytel Inc., a renowned expert in advanced analytics and software for clinical trials 1

1

. This partnership marks a significant step forward in the integration of real-world data into clinical research and development processes.

Enhancing Real-World Data Solutions

The collaboration between OneMedNet and Cytel is set to revolutionize the utilization of real-world data in the healthcare industry. OneMedNet's innovative BEAM® software platform, which provides access to regulatory-grade, de-identified clinical data, will be complemented by Cytel's expertise in advanced analytics and trial design 2

2

.

Expanding Market Reach

This strategic alliance is expected to broaden the market reach for both companies. OneMedNet's extensive network of health systems and imaging centers will now have access to Cytel's advanced analytics capabilities. Conversely, Cytel's global clientele in the biopharmaceutical and medical device industries will benefit from OneMedNet's comprehensive real-world data resources 1

1

.

Accelerating Drug Development

The partnership aims to accelerate drug development processes by leveraging real-world data more effectively. By combining OneMedNet's vast repository of clinical data with Cytel's sophisticated analytics tools, researchers and pharmaceutical companies can gain deeper insights into treatment efficacy, patient outcomes, and potential areas for innovation 2

2

.

Leadership Perspectives

Paul Casey, Chief Executive Officer of OneMedNet, expressed enthusiasm about the partnership, stating that it would "drive innovation and advance healthcare outcomes." Joshua Schultz, Chief Executive Officer of Cytel, echoed this sentiment, emphasizing the potential of the alliance to "unlock the full potential of real-world data in clinical research" 1

1

2

2

.

Impact on Clinical Trials

The collaboration is expected to have a significant impact on clinical trial design and execution. By incorporating real-world data more effectively, researchers can potentially reduce trial durations, lower costs, and improve the overall efficiency of the drug development process 2

2

.

Future Prospects

As the healthcare industry continues to embrace data-driven approaches, partnerships like the one between OneMedNet and Cytel are likely to become increasingly common. This alliance sets a precedent for how companies can collaborate to harness the power of real-world data and advanced analytics in pursuit of better healthcare outcomes and more efficient drug development processes 1

1

2

2

.